Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan McDonald

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Scientific Reports|August 24, 2022
Translational feasibility and efficacy of nasal photodynamic disinfection of SARS-CoV-2Layla Pires, Brian C Wilson, Rod Bremner, et al.
Plos One|June 17, 2024
Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborativeJoshua D Lee, Keith Goldfeld, Robert P Schwartz, et al.
Addiction Science & Clinical Practice|January 30, 2022
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative studyAnna Cheng, Ryan Badolato, Andrew Segoshi, et al.
Contemporary Clinical Trials|April 16, 2019
Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON)Mia Malone, Ryan McDonald, Alex Vittitow, et al.
JAMA Network Open|September 8, 2021
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From JailJoshua D Lee, Mia Malone, Ryan McDonald, et al.
Addiction (Abingdon, England)|October 28, 2022
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17Sungwoo Lim, Teena Cherian, Monica Katyal, et al.
Drug and Alcohol Dependence|November 4, 2022
Opioid Use Disorder Treatments: An Evidence MapAllison Sugarman, Alexandria Vittitow, Anna Cheng, et al.
Journal of Substance Use and Addiction Treatment|December 10, 2023
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysisSungwoo Lim, Teena Cherian, Monica Katyal, et al.
Drug and Alcohol Dependence|April 21, 2024
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarcerationTeena Cherian, Sungwoo Lim, Monica Katyal, et al.
BMC Public Health|January 10, 2012
Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, CanadaGeorge R Golding, Brian Quinn, Kirsten Bergstrom, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Scientific Reports|August 24, 2022
Translational feasibility and efficacy of nasal photodynamic disinfection of SARS-CoV-2Layla Pires, Brian C Wilson, Rod Bremner, et al.
Plos One|June 17, 2024
Assessing the impact of jail-initiated medication for opioid use disorder: A multisite analysis of the SOMATICS collaborativeJoshua D Lee, Keith Goldfeld, Robert P Schwartz, et al.
Addiction Science & Clinical Practice|January 30, 2022
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative studyAnna Cheng, Ryan Badolato, Andrew Segoshi, et al.
Contemporary Clinical Trials|April 16, 2019
Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON)Mia Malone, Ryan McDonald, Alex Vittitow, et al.
JAMA Network Open|September 8, 2021
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From JailJoshua D Lee, Mia Malone, Ryan McDonald, et al.
Addiction (Abingdon, England)|October 28, 2022
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17Sungwoo Lim, Teena Cherian, Monica Katyal, et al.
Drug and Alcohol Dependence|November 4, 2022
Opioid Use Disorder Treatments: An Evidence MapAllison Sugarman, Alexandria Vittitow, Anna Cheng, et al.
Journal of Substance Use and Addiction Treatment|December 10, 2023
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysisSungwoo Lim, Teena Cherian, Monica Katyal, et al.
Drug and Alcohol Dependence|April 21, 2024
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarcerationTeena Cherian, Sungwoo Lim, Monica Katyal, et al.
BMC Public Health|January 10, 2012
Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, CanadaGeorge R Golding, Brian Quinn, Kirsten Bergstrom, et al.
Pageof 4